Re: Cytotec
From: art fougner, md (evsono@pipeline.com)
Wed Apr 24 13:56:30 2002
Ashley -
right now John Paul II is coming to grips with the realization that the
Vatican is the ultimate deep pocket.
just my opinion - i could be wrong.
art
At Wed, 24 Apr 2002, D. Ashley Hill, MD wrote:
>
>At Wed, 24 Apr 2002, Richard Chudacoff, MD wrote:
>>
>>I actually think I had a great response to this guy, but I just get the
>>impression he is like all the other closed-minded, neofascist, lily-white
>>males who want to control the uteri of women he's never met.
>
>I also thought about educating Mr (Ms?) Kennedy about the FDA approval
>process and the obvious motivation behind the cowardly Searle statement
>regarding cytotec for labor induction, but, as you suggest, why bother?
>We agreed some time ago to not respond to non-professional posters. His
>comments, however, made me realize that most who are not in the medical
>field do not understand the FDA approval process and that physicians use
>medications commonly that do not have FDA approval for the reason they
>are using them. I believe that ritordrine is the only FDA approved
>tocolytic, yet physicians use other medications much more often than
>ritrodrine for this purpose. There are numerous, well-designed
>peer-reviewed journal articles from unbiased physicians documenting the
>safety of misoprostol when, like all medications, it is used
>appropriately. This research suggests that one should not use it if the
>patient has had major uterine surgery or a prior cesarean delivery, but,
>when used as part of a formal protocol, this medication is safe and
>effective. Searle tried to CYA, knowing that jury awards are going
>through the roof and that they are the ultimate deep pocket. I am not
>ignorant, nor do I or other physicians realize any economic gain from
>using misoprostol for cervical ripening/induction. We use it because
>it's effective, safe if used appropriately, and often has potential
>benefits over other medications used for ripening or induction. I
>discuss the off-label use of cytotec with my patients, and the
>risks/benefits/alternatives. After hearing this I can recall only one
>patient who declined it's use and opted for another agent.
>
>--
>D. Ashley Hill, MD
>Associate Director
>Department of Obstetrics and Gynecology
>Florida Hospital Family Practice Residency
>Orlando, Florida
>
--
art fougner, md
ich bin ein New Yorker
